Skip to main content

Table 1 Demographics of users of hormonal contraceptive treatment (n = 62)

From: Metabolic effects of the contraceptive skin patch and subdermal contraceptive implant in Mexican women: A prospective study

 

CSP (n = 25)

 

SCI (n = 37)

 

Variable

Basal

4 months

p

Basal

4 months

p

Age (years)

23.9 (18-32)*

23.9 (18-32)

NA

28.0 (18-35)*

28.0 (18-35)

NA

Weight (kg)

59.3 (42-90)

60.9 (47-88)

0.058

57.5 (36-91)

60.0 (39-101)

0.056

Height (m)

1.6 (1.5-1.7)

1.6 (1.5-1.7)

NA

1.52 (1.38-1.64)

1.52 (1.38-1.64)

NA

BMI (kg/m2)

24.6 (19.2-39)

25.3 (21.5-38.1)

0.062

24.7 (16.0-38.5)

25.8 (17.3-39.9)

0.062

AC (cm)

79 (62-110)

80.5 (64.0-109)

0.057

82 (58-101)

85.1 (60-109)

0.053

SBP (mmHg)

108 (90-120)

107 (100-120)

0.588

107 (90-120)

107 (90-120)

0.980

DBP (mmHg)

71 (60-80)

70 (60-80)

0.695

68 (60-80)

69 (68-80)

0.678

  1. Results are presented as mean (ranges). AC, abdominal circumference; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure. *p < 0.050 between basal contraceptive skin patch (CSP) vs. basal subdermal contraceptive implant (SCI).